Vascular Ulcers Treatment Market Size Projected To Reach $5.08 Billion By 2028 With CAGR of 6.1% | Bristol Myers Squibb, Sanofi, Bayer AG, Pfizer

Market Overview:

Vascular ulcers are chronic, or long term, breaches in the skin caused by problems with the vascular system. Venous ulcers typically occur because of damage to the valves inside the leg veins. Common causes of damaged veins include blood clots, injury, ageing and obesity.

Major players operating in the global vascular ulcers treatment market include, Bristol Myers Squibb Co., Bayer AG, Cadila Pharmaceuticals Ltd., Novo Nordisk A/S, Pfizer Inc., and Sanofi.

Request Free Sample Copy With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/4639

Key Market Drivers:

High prevalence of diabetic foot ulcers is expected to propel growth of the global vascular ulcers treatment market over the forecast period. For instance, the prevalence of diabetic foot ulcers was 51.8% in a community based study conducted by Kasturba Medical College, India, June 2018.

Covid-19 Impact Analysis

Globally, as of 5:48pm CET, 30 November 2021, there have been 261,435,768 confirmed cases of COVID-19, including 5,207,634 deaths, reported to WHO. As of 29 November 2021, a total of 7,772,799,316 vaccine doses have been administered. The pandemic is expected to cause delay in treatment of chronic wound as patient discontinue their visits.

Key Takeaways

High prevalence of diabetic foot ulcers is expected to propel growth of the global vascular ulcers treatment market over the forecast period. For instance, according to a study published in November 2018, the incidence of venous leg ulcers increased from 0.5 new cases per 1000 people/year in 2010 to 1 new case for every 1000 people/year in 2014.

Major players operating in the global vascular ulcers treatment market are focused on development and launch of new products to expand their product portfolio. For instance, in November 2021, Sanara MedTech Inc., a provider of products and technologies for surgical and chronic wound care, launched FORTIFY TRGTM Tissue Repair Graft, a small intestinal submucosa extracellular matrix sheet, and FORTIFY FLOWABLETM Extracellular Matrix, a wound care device indicated for the management of chronic vascular ulcers, from Cook Biotech Inc.

Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4639

Table of Content

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Overview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Disease Type
     • Market Snippet, By Drug Class
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Porter’s Analysis
   • Industry Trends
   • Key Highlights
   • Epidemiology
   • Reimbursement Scenario
   • Regulatory Scenario
   • Product Launch and Approvals
   • Acquisition and Collaboration Scenario
4.  Global Vascular Ulcers Treatment Market – Impact of Coronavirus (Covid-19) Pandemic
   
   • COVID-19 Epidemiology
   • Impact of COVID-19 on Demand and Supply of Vascular Ulcers Treatment
   • Impact of COVID-19 on the overall Healthcare Sector
5. Global Vascular Ulcers Treatment Market, By Disease Type, 2017 – 2028 (US$ Billion)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Arterial Ulcers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
   • Venous Ulcers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
   • Neurotropic Ulcers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
   • Diabetic Ulcers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
6. Global Vascular Ulcers Treatment Market, By Drug Class, 2017 – 2028 (US$ Billion)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Antibiotics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
   • Hemorrheologic Agents
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
   • Corticosteroids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
   • Non-steroidal Anti-inflammatory Drug (NSAID)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
7. Global Vascular Ulcers Treatment Market, By Distribution Channel, 2017 – 2028 (US$ Billion)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Billion)
8. Global Vascular Ulcers Treatment Market, By Region, 2017 – 2028 (US$ Billion)
   • Introduction
     • Market Share Analysis, By Region, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, For Regions, 2018 – 2028
     • Regional Trends
   • North America
     • Market Size and Forecast, By Disease Type,2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Drug Class, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Country, 2017 – 2028 (US$ Bn)
       • U.S.
       • Canada
   • Latin America
     • Market Size and Forecast, By Disease Type,2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Drug Class, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Country, 2017 – 2028 (US$ Bn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Market Size and Forecast, By Disease Type,2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Drug Class, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Country, 2017 – 2028 (US$ Bn)
       • Germany
       • U.K.
       • France
       • Italy
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast, By Disease Type,2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Drug Class, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Country, 2017 – 2028 (US$ Bn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Market Size and Forecast, By Disease Type,2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Drug Class, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Country, 2017 – 2028 (US$ Bn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Market Size and Forecast, By Disease Type,2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Drug Class, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Bn)
     • Market Size and Forecast, By Country/Region, 2017 – 2028 (US$ Bn)
       • South Africa
       • Central Africa
       • North Africa
9. Competitive Landscape
   • Company Profiles
     • Bristol Myers Squibb Co.*
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
   • Sanofi
     • Bayer AG
     • Pfizer Inc.
     • Novo Nordisk A/S
     • Cadila Pharmaceuticals Ltd.

*Key pointers provided are also applicable to other companies covered in the scope of the report.

• Analyst Views

10. Section
    • Research Methodology
    • About us
    • Contact

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏

Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/4639

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com